INS and metabolic dysfunction-associated steatotic liver disease: Hence, once the hepatic insulin signaling cascade faces impairment resulting in hepatic insulin resistance, other metabolic symptoms occur, incurring hyperglycemia, inflammation, and de novo lipogenesis, and further, hepatic steatosis and nonalcoholic fatty liver disease (NAFLD) (67).